Primer on the Rheumatic Diseases pp 488-491 | Cite as
Less Common Arthropathies
Abstract
-
Neuropathic arthropathy, also known as a Charcot joint, is a destructive arthritis characterized by fracture, subluxation, and dislocation of the articular structures in the setting of neurologic damage to the involved joint or limb.
-
Both central (upper motor neuron) and peripheral (lower motor neuron) lesions may lead to the development of neuropathic arthropathy.
-
Diabetic neuropathy is now the most common cause of neuropathic arthropathy. Neuropathic arthropathy occurs in 7.5% of diabetic patients.
-
The pathologic features of Charcot arthropathy include cartilage destruction, bone eburnation, osteophytosis, and loose body formation.
-
Two major theories have been proposed to explain the development of neuropathic arthropathy: the neurovascular theory and the neurotraumatic theory.
-
Neuropathic arthropathy typically presents as an acute or subacute monoarthritis with swelling, erythema, and variable amounts of pain in the affected joint.
-
Two consistent clinical features of neuropathic arthropathy are the presence of a significant sensory deficit and a degree of pain that is less than would be expected considering the amount of joint destruction evident on radiographs.
-
The differential diagnosis of neuropathic arthropathy includes osteomyelitis and other deep tissue infections, fracture, gout, calcium pyrophosphate dihydrate deposition disease, Milwaukee shoulder/knee syndrome, osteonecrosis, and osteoarthritis.
-
■ Plain radiographs are extremely helpful in making the diagnosis of neuropathic arthropathy. ■ Categorizing the disease into three clinical stages— acute, subacute, and remodeling—is a useful way to organize approaches to therapy.
Keywords
Diabetic Neuropathy Lower Motor Neuron Destructive Arthritis Basic Calcium Phosphate Crystal Charcot ArthropathyPreview
Unable to display preview. Download preview PDF.
References
- 1.Gupta A. A short history of neuropathic arthropathy. Clin Orthop 1993;296:43–49.PubMedGoogle Scholar
- 2.Lee L, Blume P, Sumpio B. Charcot joint disease in diabetes mellitus. Ann Vasc Surg 2003;17:571–580.PubMedCrossRefGoogle Scholar
- 3.Resnick D. Neuropathic osteoarthropathy. In: Resnick D, ed. Diagnosis of bone and joint disorders. 3rd ed. Philadelphia: Saunders; 1995:3413–3442.Google Scholar
- 4.Sinacore D, Withrington N. Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle. J Orthop Sports Phys Ther 1999;29:736–746.PubMedGoogle Scholar
- 5.Fishco W. Surgically induced Charcot’s foot. J Am Podiatr Med Assoc 2001;91:288–293.Google Scholar
- 6.Eichenholtz S. Charcot joints. Springfield: Thomas; 1966.Google Scholar
- 7.Sloman-Kovacs S, Braunstein E, Brandt K. Rapidly progressive Charcot arthropathy following minor joint trauma in patients with diabetic neuropathy. Arthritis Rheum 1990;33:412–417.CrossRefGoogle Scholar
- 8.Lipman B, Collier B, Carrera G, et al. Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI, and conventional radiography. Clin Nucl Med 1998;23: 77–82.PubMedCrossRefGoogle Scholar
- 9.Palestro C, Mehta H, Patel M, et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med 1998; 39:346–350.PubMedGoogle Scholar
- 10.Saltzman C, Hagy M, Zimmerman B, Estin M, Cooper R. How effective is intensive nonoperative intial treatment of patients with diabetes and Charcot arthropathy of the feet? Clin Orthop 2005;435:185–190.PubMedGoogle Scholar